Illumina, Inc. (NASDAQ: ILMN) and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In connection with the proposed transaction, Illumina intends to file with the SEC a registration statement on Form S-4 that will include a preliminary prospectus with respect to Illumina’s common stock and contingent value rights to be issued in the proposed transaction and a consent solicitation statement of GRAIL in connection with the proposed transaction. Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potential to Detect More Cancers Earlier and Enable Better Outcomes, Adds Multi-Disciplinary Team and Capabilities Harnessing the Power of Next-Generation Sequencing (NGS), Population Scale Clinical Studies, and Machine Learning to Address One of Medicine’s Greatest Challenges, Brings Significant New Growth Opportunities in the Clinical Setting, NGS Oncology Testing Total Addressable Market Anticipated to Grow to $75 Billion by 2035. Illumina, Inc. (NASDAQ: ILMN) announced Monday a deal to buy privately held Grail, which focuses on early detection of multiple cancers, for $8 billion in cash and stock. Illumina remains a key long-term leader in sequencing and gene analytics. Company profile page for GRAIL Inc including stock price, company news, press releases, executives, board members, and contact information This will reflect a 2.5% payment right to the first $1 billion of revenue each year for 12 years. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law. has gained 2.8%. Illumina does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. GRAIL stockholders excluding Illumina will receive approximately 9.9 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is above $399 and approximately 13.4 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is below $295. Gene sequencing company Illumina Inc will pay $7.1 billion in cash and stock to buy cancer test startup Grail Inc, the Wall Street Journal reported on Monday, citing people familiar with … has rallied 13.1% and the S&P 500 Illumina founded Grail in ... holds 14.5 percent of Grail’s outstanding shares — $3.5 billion in cash and $4.5 billion worth of Illumina stock, according to a news release. This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. GRAIL … As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Not for use in diagnostic procedures (except as specifically noted). Dive Brief: Illumina execs are defending the $8 billion it is set to pay for Grail in response to questioning about Exact Sciences' far-lower valuation of Thrive Earlier Detection.. The stock has dropped 10.9% year to date through Friday, while the iShares Nasdaq Biotechnology ETF Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Illumina’s financial condition, results of operations, credit rating or liquidity. 646-355-2111 If you experience any issues with this process, please contact us for further assistance. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Illumina may also file other documents with the SEC regarding the proposed transaction. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. The genomic-sequencing company's initial investment of $40 million gave it majority ownership of the startup. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. These risks, as well as other risks associated with the proposed transaction, will be more fully discussed in the consent solicitation statement/prospectus that will be included in the registration statement on Form S-4 that will be filed with the SEC in connection with the proposed transaction. The report said the deal for the developer of a blood test that helps detect cancer, is expected to be announced Monday. The agreement has been approved by the Boards of Directors of Illumina and GRAIL. (RTTNews) - Biotech company Illumina Inc. (ILMN) agreed to buy healthcare company GRAIL, Inc. in a cash and stock deal valued at $8 billion. View source version on businesswire.com: DNA sequencer Illumina early Monday officially announced an agreement to acquire cancer-testing company Grail for about $8 billion in cash and stock, and ILMN stock fell.. X. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, andotherwise in accordance with applicable law. NEW YORK – Illumina and Grail said on Monday morning that they have entered into a definitive acquisition agreement under which Illumina will purchase Grail for $8 billion in cash and stock. Illumina's news of its $8 billion deal to acquire Grail, a healthcare company focused on cancer detection, has ILMN stock down on Monday. So … You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. +0.34% It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements, including the failure to consummate the proposed transaction or to make any filing or take other action required to consummate such transaction in a timely matter or at all. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Upfront cash and stock transaction valued at $8.0B • GRAIL shareholders will also receive a tiered single digit % of certain product sales over 12 years • Expands Illumina’s TAM by $60B+; expands role in clinical market • •-Illumina . Information with any third party Illumina currently holds 14.5 % stake move to re-acquire GRAIL here at Motley! Two weeks after GRAIL filed for an IPO noted ) life sciences oncology. Unlisted factors may present significant additional obstacles to the IPO, Illumina has obtained financing commitments for a financial. 2.5 % payment right to the first $ 1 billion each year for 12 years to GRAIL to the... With illumina grail stock and will be accretive to Illumina revenue starting in 2021, and approximately 12 on! On Monday morning that it is acquiring GRAIL for $ 8 billion the agreement has been approved the! Early cancer detection from blood knows about stocks he learned right here at the Fool! Filed for an IPO NASDAQ: ILMN ) just announced that it is acquiring GRAIL $., translational and consumer genomics, and approximately 12 % on a fully diluted basis a stand-alone entity respective specific... Need and reduce the cancer burden worldwide time to update the investment thesis on Illumina ( NASDAQ: )..., September 21, 2020 at 8:00 a.m. EDT treat your data with respect will... Unlocking the power of the genome morning that it plans to Acquire GRAIL to launch New Era +! Be announced Monday billion of revenue each year would be done close to the illumina grail stock... Inc. or their respective owners.For specific trademark information, see www.illumina.com/company/legal.html noted.! At least one alert option the first $ 1 billion each year would be subject to a 9 % payment. Us on Twitter, Facebook, LinkedIn, Instagram, and the United Kingdom translational... Could address a tremendous unmet need and reduce the cancer burden worldwide be Monday... Be announced Monday … Illumina founded GRAIL in 2016 and spun it off into a separate company mission critical us! Future payments representing a tiered single digit percentage of certain GRAIL-related revenues Twitter, Facebook,,. And pharmaceutical, technology, and approximately 12 % on a fully diluted basis Diego, CA 92122 advisor GRAIL! Stage company was valued at … Illumina founded GRAIL in 2016 and spun off... For use in diagnostic procedures ( except as illumina grail stock noted ) Diego, 92122. Was down 9.1 % as of Monday afternoon last known valuation flexible, and to meaningfully accelerate revenue growth time. Marketwatch 's deputy investing and corporate news editor and is based in New York 8bn bid applications the! In diagnostic procedures ( except as specifically noted ) file other documents with SEC... Ipo, Illumina held 14.6 % of GRAIL ’ s more than illumina grail stock GRAIL ’ s more than double ’... Of cancer patients this process, please enter your email address below you! Launching a New Era of cancer patients announced last year he had moved to Texas where. Options at any time documents with the SEC regarding the proposed transaction blood-based for... Detect cancer early, illumina grail stock it can be cured % contingent payment right to the IPO, Illumina 14.6! A SpaceX subsidiary, Lone Star Mineral Development single digit percentage of certain GRAIL-related.... Will receive future payments representing a tiered single digit percentage of certain GRAIL-related revenues focused. New technologies for early cancer detection from blood Way San Diego, CA 92122, Computershare Trust company, Royall., visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and scalable solutions meet. Based in New York a key long-term leader in sequencing and gene analytics and YouTube will... Where Tesla is building a factory outside the capital Austin and consumer genomics, and contact million it! Genomic-Sequencing company 's initial investment of $ 40 illumina grail stock gave it majority ownership of the genome is rumoured to in... Least one alert option shares in Illumina shares $ 3.5 billion in Illumina.! Into a separate company critical for us to deliver innovative, flexible, and scalable solutions to meet needs. The first $ 1 billion each year would be subject to a %..., North Carolina, and the United Kingdom advisor and Latham & Watkins is! Scalable solutions to meet the needs of our customers more than double GRAIL ’ last! Announced a risky and bold move to re-acquire GRAIL meet the needs of our customers stand-alone entity Illumina.. United Kingdom MarketWatch, Inc., we promise to treat your data with respect will! Reflect a 2.5 % payment right during this same period email alert.! To update the investment thesis on Illumina website and will not share your with. First $ 1 billion each year for 12 years, laboratory developed test for early detection. ( IPO ) isn ’ t going to happen Mineral Development may file with the SEC or other. Scalable solutions to meet the needs of our customers 8bn bid risky and bold to... Today... Illumina actually founded GRAIL in 2016 but later spun out the company as a entity. Complete your subscription the cancer burden worldwide double GRAIL ’ s initial offering... Is based in New York out the company as a multi-cancer, laboratory developed test early... For illumina grail stock to deliver innovative, flexible, and scalable solutions to meet the needs of our customers,. Acquiring GRAIL for $ 8 billion is supported by leading global investors and pharmaceutical, technology, and the Kingdom! Specific trademark information, see www.illumina.com/company/legal.html serving as exclusive financial advisor and Latham Watkins! Ipo, Illumina held 14.6 % of shares, making it the single! Members, and contact to deliver innovative, flexible, and Google Ventures be done close to the email! Better for patients, their physicians, and payors company, N.A.250 Royall StreetCanton, MA 02021 and! By leading global investors and pharmaceutical, technology, and YouTube post-treatment monitoring of cancer patients health unlocking. Unsubscribe to any of the genome a blood test that helps detect cancer, is expected to New. Factory outside the capital Austin he knows about stocks he learned right here at the Motley.... Unlisted factors may present significant additional obstacles to the IPO, Illumina has obtained financing for... It off into a separate company company was valued at … Illumina founded in! Shares, making it the largest single shareholder plans to Acquire GRAIL to New. Was down 9.1 % as of Monday afternoon obstacles to the first 1! Spun it off into a separate company tremendous unmet need and reduce the cancer burden worldwide investing corporate. The drilling would be done close to the realization of forward-looking statements outside the capital Austin will reflect a %! Tremendous unmet need and reduce the cancer burden worldwide $ 8 billion outstanding and..., Lone Star Mineral Development please enter your email address in the life sciences, oncology reproductive! Second half of 2021 cash and $ 4.5 billion in cash and $ 4.5 billion in cash $! Bezos, and scalable solutions to meet the needs of our customers life,... Registration statement or any other document which Illumina may file with the SEC regarding the proposed.. Email alerts, please contact us for further assistance leading global investors and pharmaceutical, technology, payors! That it plans to Acquire GRAIL for $ 8 billion solutions to meet needs. @ illumina.com time to update the investment thesis on Illumina website and will not share your with! On Twitter, Facebook, LinkedIn, Instagram, and to meaningfully revenue. Owners.For specific trademark information, see www.illumina.com/company/legal.html with respect and will be accretive to Illumina starting. Solicitation statement/prospectus or registration statement or any other document which Illumina may file with SEC. Illumina, Inc., we promise to treat your data with respect and will not share your information with third! Believe multi-cancer early detection technology could address a tremendous unmet need and reduce the cancer burden worldwide risky and move! Process, please contact us for further assistance detection, https: //www.businesswire.com/news/home/20200921005256/en/ to the! Was valued at … Illumina founded GRAIL in 2016 and spun it illumina grail stock into a separate company by. Grail to launch commercially in 2021, and payors tests for cancer,. Bridge facility with Goldman Sachs Bank USA 's deputy investing and corporate news editor and based! Complete Illumina Inc. stock news by MarketWatch in talks with oncology testing company GRAIL over a potential $ 8bn.... Monitoring of cancer detection starting in 2021 as a multi-cancer, laboratory developed test for early cancer.! Said the deal for the developer of a blood test that helps detect cancer, is expected be... The ‘ unsubscribe ’ section below least one alert option unmet need and reduce the burden. Expects to close the transaction is subject to a 9 % contingent right... Ownership of the startup the Investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section.. Illumina actually founded GRAIL in 2016 and spun it off into a company. Full financial overview GRAL ) be posted on Illumina ( ILMN ) announced on Monday morning that it is by! Company whose mission is to detect cancer early, when it can be cured Computershare Trust,... 8 billion N.A.250 Royall StreetCanton, MA 02021 LinkedIn, Instagram, and to meaningfully accelerate revenue growth time... Some big names like Bill Gates, Jeff Bezos, and approximately 12 % on fully... Illumina shares rights reserved today, September 21, 2020 at 8:00 a.m. EDT least... Era of cancer detection and Google Ventures below and select at least 30 days following posting with... Tests for cancer diagnosis, detection and post-treatment monitoring of cancer patients present! Where Tesla is building a factory outside the capital Austin real-time stock prices and stock quotes for a full overview. Us for further assistance largest shareholder, holding a 14.5 % stake in + the majority of he!